Novartis to invest CHF70 million in a new Swiss production unit
The production unit will be developed in an existing building in the Schweizerhalle industrial area on the outskirts of Basel.
Keystone / Gaetan Bally
The Swiss pharmaceutical company has announced that it is constructing a new production unit for experimental drugs on the outskirts of the city of Basel.
This content was published on
1 minute
SDA-Keystone/ac
The CHF70 million (around $77.5 million) investment will give it two new production lines, Novartis said on Tuesday. Both will be dedicated to producing active ingredients for experimental medicines. The production lines will be developed in an existing building in the Schweizerhalle industrial area on the outskirts of Basel.
These new facilities will be commissioned at the end of next year. This investment confirms the importance of Schweizerhalle as a global production site, Novartis said.
Popular Stories
More
Swiss Politics
Swiss reject plans for bigger motorways and extra rights for landlords
Should Switzerland take measures to support its struggling industries?
Industrial policies are back in fashion, not only in the United States but also in the EU. Should Switzerland, where various industries are struggling, draw inspiration from such policies?
Solar energy covers 11% of Switzerland’s electricity needs
This content was published on
Solar power covers eleven percent of the electricity demand in Switzerland. The industry's turnover for the current year is around CHF 3.7 billion, as shown by the first ever publication of the Swiss Solar Monitor.
This content was published on
The recovery in Swiss industry is a long time coming. The managers responsible for purchasing have lowered their assessments again. By contrast, the services PMI remained in growth territory in November.
This content was published on
Switzerland is concerned about the escalation of hostilities in Syria. It calls on all parties to respect international law and protect the civilian population.
Trial opens into 1995 murder in Geneva of Egyptian diplomat
This content was published on
The Criminal Chamber of the Federal Criminal Court opened the main hearing in the case of the murder of an Egyptian diplomat in Geneva in 1995 on Monday.
This content was published on
Museum attendance is back on the rise in Switzerland. Nearly 15 million admissions were recorded in 2023, 12% more than the 2015-2019 average prior to the Covid crisis.
This content was published on
Immigration, support for Ukraine and pandemic measures polarise opinions and emotions in Switzerland particularly strongly.
This content was published on
The abolition of all tax concessions with a climate impact can reduce carbon dioxide emissions by 2.5 million tonnes per year, according to a study by the EPFL.
Swiss corruption case involving Trafigura and former executive opens
This content was published on
Trafigura and three other defendants including a former board member go on trial over the alleged payment of bribes to an Angolan oil official for oil deals in a landmark case that opens on Monday.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Covid cure further away than hoped, says Novartis chief
This content was published on
Swiss pharmaceutical firm Novartis has rowed back on earlier predictions that a drug to combat coronavirus could be on the horizon.
This content was published on
Swiss drug giant Novartis is ending its trial of malaria drug hydroxychloroquine against Covid-19 after failing to find enough participants.
This content was published on
Around 1,500 jobs are affected in production and 700 in services. Novartis currently employs 13,000 people across Switzerland.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.